Tech Company Financing Transactions
Auris Health Funding Round
Coatue Management, Highland Capital Partners and Lux Capital participated in a $280 million Series D funding round for Auris Health. The round was announced on 8/5/2017.
Transaction Overview
Company Name
Announced On
8/5/2017
Transaction Type
Venture Equity
Amount
$280,000,000
Round
Series D
Investors
Coatue Management (Lead Investor)
Mithril Capital Management (Peter Thiel)
Proceeds Purpose
Auris announced its newest round of funding in an easy-to-miss paragraph on its website, and it's been similarly low key about its work to date, though it says that lung cancer is the first disease in its sights.
Company Information
Company Status
Acquired or Merged
Industry
Robotics
Mailing Address
150 Shoreline Dr.
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Not Recorded
Overview
Auris Health engages in the development of robotics technology for medical applications. The company designs novel dualarm microsurgical system for ophthalmic surgery. The company was incorporated in 2007.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fred Moll
Chief Financial Officer
David Styka
VP - Bus. Development
Josh Defonzo
VP - Bus. Development
David Schummers
VP - Engineering
Richard Leparmentier
VP - Operations
Daniel Bradford
VP - R & D
David Mintz
VP - Sales
Eric Davidson
Browse more venture capital transactions:
Prev: 8/5/2017: Auris Health venture capital transaction
Next: 8/5/2017: Tokyo Smoke venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs